Method
Between July 1992 and January 1995, 140 patients underwent salvage cryoablation for local recurrence. Of these, 37 had evidence of androgen-independent disease following various combinations of hormonal therapy, radiation therapy and systemic chemotherapy; 103 had received radiation therapy only. Treatment failure was de®ned as a rise in serum prostate-speci®c antigen (PSA) OF 2.0 ngaml from the nadir level, a positive prostate biopsy or evidence of metastatic disease.
Results
The mean follow-up was 4.8 y (1.5±6.3 y). Of the 140 patients, 60 (43%) remained free of disease. Eighty patients had treatment failure, of whom 71 had a rise in PSA, 24 a positive biopsy of the prostate, 18 a positive bone scan and 21 a positive CT scan. Thirty-eight patients died, 29 of prostate cancer and nine of other causes. Of the 37 patients with clinical evidence of androgen-independent prostate cancer at the time of cryotherapy, 19 died of metastatic disease compared with 10 who had no evidence of androgen-independence.
Conclusion
The likelihood of curing a patient after salvage cryotherapy is small. Patients with clinical evidence of androgenindependent prostate cancer before salvage cryotherapy have a higher risk of disease-speci®c death than patients who have androgen-sensitive disease.
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